Submitted by Anonymous (not verified) on 22 September 2026 - 16:20
Human medicines European public assessment report (EPAR): mCombriax, influenza mRNA vaccine,COVID-19 mRNA vaccine, Date of authorisation: 20/04/2026, Revision: 1, Status: Authorised
Source: